CN111686024A - 含有柿叶提取物的氨基酸面膜及其制备方法 - Google Patents
含有柿叶提取物的氨基酸面膜及其制备方法 Download PDFInfo
- Publication number
- CN111686024A CN111686024A CN202010589805.XA CN202010589805A CN111686024A CN 111686024 A CN111686024 A CN 111686024A CN 202010589805 A CN202010589805 A CN 202010589805A CN 111686024 A CN111686024 A CN 111686024A
- Authority
- CN
- China
- Prior art keywords
- coenzyme
- persimmon leaf
- amino acid
- facial mask
- vitamin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 244000236655 Diospyros kaki Species 0.000 title claims abstract description 81
- 230000001815 facial effect Effects 0.000 title claims abstract description 41
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 35
- 239000000284 extract Substances 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 10
- 235000008597 Diospyros kaki Nutrition 0.000 title description 6
- 235000011511 Diospyros Nutrition 0.000 claims abstract description 75
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 47
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 40
- 229920001184 polypeptide Polymers 0.000 claims abstract description 39
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 39
- 229940024606 amino acid Drugs 0.000 claims abstract description 32
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 claims abstract description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 21
- LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 claims abstract description 17
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 17
- 229920002125 Sokalan® Polymers 0.000 claims abstract description 17
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 claims abstract description 17
- 229940069521 aloe extract Drugs 0.000 claims abstract description 17
- 229960001631 carbomer Drugs 0.000 claims abstract description 17
- 229950001485 cocarboxylase Drugs 0.000 claims abstract description 17
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 17
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 claims abstract description 17
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 17
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 17
- YXVCLPJQTZXJLH-UHFFFAOYSA-N thiamine(1+) diphosphate chloride Chemical compound [Cl-].CC1=C(CCOP(O)(=O)OP(O)(O)=O)SC=[N+]1CC1=CN=C(C)N=C1N YXVCLPJQTZXJLH-UHFFFAOYSA-N 0.000 claims abstract description 17
- RGJOEKWQDUBAIZ-IBOSZNHHSA-N CoASH Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS)O[C@H]1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-IBOSZNHHSA-N 0.000 claims abstract description 16
- PGAVKCOVUIYSFO-XVFCMESISA-N UTP Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-XVFCMESISA-N 0.000 claims abstract description 16
- 229940093530 coenzyme a Drugs 0.000 claims abstract description 16
- 229950010342 uridine triphosphate Drugs 0.000 claims abstract description 16
- PGAVKCOVUIYSFO-UHFFFAOYSA-N uridine-triphosphate Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)OC1N1C(=O)NC(=O)C=C1 PGAVKCOVUIYSFO-UHFFFAOYSA-N 0.000 claims abstract description 16
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000005516 coenzyme A Substances 0.000 claims abstract description 15
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 claims abstract description 15
- XJLXINKUBYWONI-NNYOXOHSSA-N NADP zwitterion Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP([O-])(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](OP(O)(O)=O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 XJLXINKUBYWONI-NNYOXOHSSA-N 0.000 claims abstract description 14
- -1 nicotinamide adenine dinucleotide nucleic acid Chemical class 0.000 claims abstract description 14
- 229950006238 nadide Drugs 0.000 claims abstract description 13
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims abstract description 13
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 13
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 13
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 claims abstract description 12
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 claims abstract description 12
- 239000011714 flavin adenine dinucleotide Substances 0.000 claims abstract description 12
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 claims abstract description 12
- 239000005515 coenzyme Substances 0.000 claims abstract description 11
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 11
- 229940088594 vitamin Drugs 0.000 claims abstract description 11
- 229930003231 vitamin Natural products 0.000 claims abstract description 11
- 235000013343 vitamin Nutrition 0.000 claims abstract description 11
- 239000011782 vitamin Substances 0.000 claims abstract description 11
- 229960002216 methylparaben Drugs 0.000 claims abstract description 6
- 229960005150 glycerol Drugs 0.000 claims abstract description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 32
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 21
- 239000002994 raw material Substances 0.000 claims description 19
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 18
- 239000004472 Lysine Substances 0.000 claims description 18
- 238000003756 stirring Methods 0.000 claims description 18
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 17
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 17
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 17
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 17
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 17
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 17
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 17
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 17
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 17
- 229960000310 isoleucine Drugs 0.000 claims description 17
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 17
- 229930182817 methionine Natural products 0.000 claims description 17
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 17
- 239000004474 valine Substances 0.000 claims description 17
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 16
- 239000004473 Threonine Substances 0.000 claims description 16
- 229930003427 Vitamin E Natural products 0.000 claims description 16
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 16
- 235000011187 glycerol Nutrition 0.000 claims description 16
- 235000019165 vitamin E Nutrition 0.000 claims description 16
- 229940046009 vitamin E Drugs 0.000 claims description 16
- 239000011709 vitamin E Substances 0.000 claims description 16
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 229930003268 Vitamin C Natural products 0.000 claims description 15
- 235000019154 vitamin C Nutrition 0.000 claims description 15
- 239000011718 vitamin C Substances 0.000 claims description 15
- 239000007788 liquid Substances 0.000 claims description 13
- 239000000203 mixture Substances 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 13
- 239000011259 mixed solution Substances 0.000 claims description 12
- 229930024421 Adenine Natural products 0.000 claims description 10
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 10
- 229960000643 adenine Drugs 0.000 claims description 10
- 239000004744 fabric Substances 0.000 claims description 10
- 239000008213 purified water Substances 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 8
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 8
- 230000007062 hydrolysis Effects 0.000 claims description 8
- 238000006460 hydrolysis reaction Methods 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000000108 ultra-filtration Methods 0.000 claims description 7
- 238000005520 cutting process Methods 0.000 claims description 6
- 239000007791 liquid phase Substances 0.000 claims description 6
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000010008 shearing Methods 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 229960003136 leucine Drugs 0.000 claims description 4
- 229960003646 lysine Drugs 0.000 claims description 4
- 229960004452 methionine Drugs 0.000 claims description 4
- 229960005190 phenylalanine Drugs 0.000 claims description 4
- 150000003384 small molecules Chemical class 0.000 claims description 4
- 229960002898 threonine Drugs 0.000 claims description 4
- 229960004799 tryptophan Drugs 0.000 claims description 4
- 229960004295 valine Drugs 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 3
- 150000001875 compounds Chemical class 0.000 claims description 3
- 230000010355 oscillation Effects 0.000 claims description 3
- 108090000145 Bacillolysin Proteins 0.000 claims description 2
- 108091005658 Basic proteases Proteins 0.000 claims description 2
- 108091005507 Neutral proteases Proteins 0.000 claims description 2
- 102000035092 Neutral proteases Human genes 0.000 claims description 2
- 235000017471 coenzyme Q10 Nutrition 0.000 claims description 2
- 230000003301 hydrolyzing effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 12
- 230000032683 aging Effects 0.000 abstract description 9
- 230000003020 moisturizing effect Effects 0.000 abstract description 9
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 238000006243 chemical reaction Methods 0.000 abstract description 2
- 230000037384 skin absorption Effects 0.000 abstract description 2
- 231100000274 skin absorption Toxicity 0.000 abstract description 2
- 238000004321 preservation Methods 0.000 abstract 1
- 229960004418 trolamine Drugs 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 10
- 230000002087 whitening effect Effects 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- 208000026935 allergic disease Diseases 0.000 description 4
- 239000003797 essential amino acid Substances 0.000 description 4
- 235000020776 essential amino acid Nutrition 0.000 description 4
- 206010020751 Hypersensitivity Diseases 0.000 description 3
- 230000003266 anti-allergic effect Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 230000007815 allergy Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000035790 physiological processes and functions Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 244000055850 Diospyros virginiana Species 0.000 description 1
- 235000011508 Diospyros virginiana Nutrition 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000018997 Growth Hormone Human genes 0.000 description 1
- 108010051696 Growth Hormone Proteins 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010048245 Yellow skin Diseases 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 150000003278 haem Chemical class 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 150000002482 oligosaccharides Polymers 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000000341 threoninyl group Chemical group [H]OC([H])(C([H])([H])[H])C([H])(N([H])[H])C(*)=O 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/35—Ketones, e.g. benzophenone
- A61K8/355—Quinones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/41—Amines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A61K8/4913—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
- A61K8/492—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid having condensed rings, e.g. indol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4953—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
- A61K8/606—Nucleosides; Nucleotides; Nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
- A61K8/65—Collagen; Gelatin; Keratin; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Cosmetics (AREA)
Abstract
含有柿叶提取物的氨基酸面膜及其制备方法，本发明涉及一种美容面膜及其制备方法，它为了解决现有美容面膜的保湿、抗衰效果有待提高的问题。本发明面膜精华液包括卡波姆B型、三乙醇胺、甘油、透明质酸钠、对羟基苯甲酸甲酯、维生素、EDTA‑二钠、柿叶活性小分子多肽、芦荟提取物、八种氨基酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸、辅酶Q‑10和余量的水。本发明添加了氨基酸及七种辅酶，吸收后能够通过改善人体的微环境，由内而外的焕发生机，达到保湿、抗衰的效果，柿叶活性小分子多肽具有更加优越的水溶性，更加利于皮肤吸收和转化，吸收的更加充分。
Description
技术领域
本发明涉及一种美容面膜及其制备方法。
背景技术
面膜，是护肤品中的一个类别。面膜的几大主要功能就是补水保湿、美白、抗衰老、平衡油脂。
市面上的面膜具有多种，但是绝大部分是使用化学制品或植物提取物等人体正常代谢之外的外来原料作用于面部达到美容的目的。这样的做法属于治标不治本，导致美容效果，或者美容养颜效果不明显。
发明内容
本发明的目的是为了解决现有美容面膜的保湿、抗衰效果有待提高的问题，而提供一种含有柿叶提取物的氨基酸面膜及其制备方法。
本发明含有柿叶提取物的氨基酸面膜包括面膜精华液和面膜布，其中面膜精华液包括卡波姆B型、三乙醇胺、甘油、透明质酸钠、对羟基苯甲酸甲酯、维生素C、维生素E、EDTA-二钠、柿叶活性小分子多肽、芦荟提取物、赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸、辅酶Q-10和余量的水。
本发明含有柿叶提取物的氨基酸面膜的制备方法按照以下步骤实现：
一、按照质量百分含量称取卡波姆B型1％～3％、三乙醇胺0.08％～0.2％、甘油8％～14％、透明质酸钠0.8％～1.4％、对羟基苯甲酸甲酯0.08％～0.12％、维生素C 0.3％～0.6％、维生素E 0.3％～0.6％、EDTA-二钠0.08％～0.12％、柿叶活性小分子多肽3％～6％、芦荟提取物0.3％～0.6％、赖氨酸0.3％～0.6％、色氨酸0.3％～0.6％、苯丙氨酸0.3％～0.6％、甲硫氨酸0.3％～0.6％、苏氨酸0.3％～0.6％、异亮氨酸0.3％～0.6％、亮氨酸0.3％～0.6％、缬氨酸0.3％～0.6％、辅羧酶0.3％～0.6％、辅酶A0.3％～0.6％、黄素腺嘌呤二核苷酸0.3％～0.6％、烟酰胺腺嘌呤二核苷酸核酸0.3％～0.6％、辅酶II 0.3％～0.6％、尿苷三磷酸0.3％～0.6％、辅酶0.3％～0.6％，余量为纯化水作为面膜精华液原料；
二、将步骤一原料中的纯化水、卡波姆、甘油、对羟基苯甲酸甲酯、EDTA-二钠、芦荟提取物混合加热到75℃～85℃，搅拌均匀，得到精华基液；
三、精华基液冷却至35℃～39℃后，采用超声波进行均质混合，得到混合剂；
四、向混合剂中加入原料中的透明质酸钠、维生素C和维生素E，搅拌均匀，得到含有维生素的混合剂；
五、向含有维生素的混合剂中加入原料中的赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸和辅酶Q-10，混合均匀，得到含有氨基酸的混合液；
六、将柿子叶(Diospyros kaki)在无菌情况下，使用无菌剪机械剪成叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于55℃～65℃震荡水解处理，离心收集上清液，然后将上清液放入10KD超滤管中离心，收集的液相为柿叶活性小分子多肽，柿叶活性小分子多肽与含有氨基酸的混合液混合，得到含有柿叶活性小分子多肽的混合液；
七、向含有柿叶活性小分子多肽的混合液加入三乙醇胺调节体系的pH为5-7，搅拌混合均匀，得到精华液；
八、将精华液吸收于面膜布上，得到含有柿叶提取物的氨基酸面膜。
本发明除了添加一般的补水保湿美容材料以外，还添加了八种人体不能在体内自身生成，而又必须由外部获得以维持正常生理机能的必须氨基酸及七种辅酶，吸收后能够通过改善人体的微环境，由内而外的焕发生机，达到美容养颜的效果。
同时添加了柿叶活性小分子多肽，柿叶具有补水、美白、抗过敏的功效，可有效清除氧自由基，这种阻止氧化的能力是维生素E的十倍以上，可以阻止细胞的退化、衰老，并且可以抑制炎性生物酶的渗出，可以增进皮肤愈合和镇静，可以用于各类敏感症，可以控制皮肤炎症从而起到抗过敏的能力。柿叶活性小分子多肽具有更好地水溶性，以及含有吸湿保湿性，能够更快地被人体所吸收。
本发明含有柿叶提取物的氨基酸面膜由面膜精华液、面膜布及珠光膜组成。面膜精华液成分包括卡波姆B型、三乙醇胺、甘油、透明质酸钠、对羟基苯甲酸甲酯、维生素C、维生素E、EDTA-二钠、柿叶活性小分子多肽、芦荟提取物、赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸、辅酶Q-10。
其中赖氨酸作为机体必需氨基酸，参与体内多种蛋白质的合成，增加机体赖氨酸有助于增加胶原蛋白的合成。
色氨酸可参与动物体内血浆蛋白质的更新，并可促使核黄素发挥作用，增强代谢还有助于烟酸及血红素的合成。
苯丙氨酸能够促进机体的糖代谢和脂肪代谢。
甲硫氨酸可以促进体内蛋白质合成，有助于体内氧自由基代谢，提高抗氧化能力
苏氨酸结构中含有羟基，对人体皮肤具有持水作用，与寡糖链结合，对保护细胞膜起重要作用，在体内能促进磷脂合成。
异亮氨酸与亮氨酸协同作用包括修复肌肉，控制血糖，并给身体组织提供能量。它还提高生长激素的产量，并帮助燃烧内脏脂肪。
缬氨酸能够促进身体正常生长，修复组织，调节血糖，还帮助从肝脏清除潜在的毒素，改善全身肤质。
七种辅酶配合八种必须氨基酸使用可以达到促进代谢循环、排出毒素、增强胶原蛋白合成并且能够调节血糖帮助脂肪燃烧的作用，由内而外的改变肤质。
本发明添加了八种人体不能在体内自身生成，而又必须由外部获得以维持正常生理机能的必须氨基酸及七种辅酶，吸收后能够通过改善人体的微环境，由内而外的焕发生机，达到美容养颜的效果。各成分配伍长期试用可以从根本上改善身体机能，停用后仍然能够保持美白、保湿、抗衰的效果。
柿叶水解超滤后获得的活性小分子多肽具有更加优越的水溶性，小分子多肽的结构使其比普通的柿叶提取物更加利于皮肤吸收和转化，能够更快起效，并且由于吸收的更加充分，停用后能够保持更长的时间，对肌肤状态能够起到根本性的改善。
具体实施方式
具体实施方式一：本实施方式含有柿叶提取物的氨基酸面膜包括面膜精华液和面膜布，其中面膜精华液包括卡波姆B型、三乙醇胺、甘油、透明质酸钠、对羟基苯甲酸甲酯、维生素C、维生素E、EDTA-二钠、柿叶活性小分子多肽、芦荟提取物、赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸、辅酶Q-10和余量的水。
具体实施方式二：本实施方式与具体实施方式一不同的是面膜精华液包括卡波姆B型1％～3％、三乙醇胺0.08％～0.2％、甘油8％～14％、透明质酸钠0.8％～1.4％、对羟基苯甲酸甲酯0.08％～0.12％、维生素C 0.3％～0.6％、维生素E 0.3％～0.6％、EDTA-二钠0.08％～0.12％、柿叶活性小分子多肽3％～6％、芦荟提取物0.3％～0.6％、赖氨酸0.3％～0.6％、色氨酸0.3％～0.6％、苯丙氨酸0.3％～0.6％、甲硫氨酸0.3％～0.6％、苏氨酸0.3％～0.6％、异亮氨酸0.3％～0.6％、亮氨酸0.3％～0.6％、缬氨酸0.3％～0.6％、辅羧酶0.3％～0.6％、辅酶A0.3％～0.6％、黄素腺嘌呤二核苷酸0.3％～0.6％、烟酰胺腺嘌呤二核苷酸核酸0.3％～0.6％、辅酶II 0.3％～0.6％、尿苷三磷酸0.3％～0.6％、辅酶Q-100.3％～0.6％和余量的水。
具体实施方式三：本实施方式与具体实施方式一或二不同的是所述的柿叶活性小分子多肽的制备方法如下：
将柿子叶(Diospyros kaki)在无菌情况下，使用无菌剪机械剪成叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于55℃～65℃温度下震荡水解处理，离心收集上清液，然后将上清液放入10KD超滤管中离心，收集的液相即为柿叶活性小分子多肽。
具体实施方式四：本实施方式与具体实施方式一至三之一不同的是该含有柿叶提取物的氨基酸面膜在面膜布上还贴附有珠光膜。
具体实施方式五：本实施方式含有柿叶提取物的氨基酸面膜的制备方法按照以下步骤实施：
一、按照质量百分含量称取卡波姆B型1％～3％、三乙醇胺0.08％～0.2％、甘油8％～14％、透明质酸钠0.8％～1.4％、对羟基苯甲酸甲酯0.08％～0.12％、维生素C 0.3％～0.6％、维生素E 0.3％～0.6％、EDTA-二钠0.08％～0.12％、柿叶活性小分子多肽3％～6％、芦荟提取物0.3％～0.6％、赖氨酸0.3％～0.6％、色氨酸0.3％～0.6％、苯丙氨酸0.3％～0.6％、甲硫氨酸0.3％～0.6％、苏氨酸0.3％～0.6％、异亮氨酸0.3％～0.6％、亮氨酸0.3％～0.6％、缬氨酸0.3％～0.6％、辅羧酶0.3％～0.6％、辅酶A0.3％～0.6％、黄素腺嘌呤二核苷酸0.3％～0.6％、烟酰胺腺嘌呤二核苷酸核酸0.3％～0.6％、辅酶II 0.3％～0.6％、尿苷三磷酸0.3％～0.6％、辅酶0.3％～0.6％，余量为纯化水作为面膜精华液原料；
二、将步骤一原料中的纯化水、卡波姆、甘油、对羟基苯甲酸甲酯、EDTA-二钠、芦荟提取物加热到75℃～85℃，搅拌均匀，得到精华基液；
三、精华基液冷却至35℃～39℃后，采用超声波进行均质混合，得到混合剂；
四、向混合剂中加入原料中的透明质酸钠、维生素C和维生素E，搅拌均匀，得到含有维生素的混合剂；
五、向含有维生素的混合剂中加入原料中的赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸和辅酶Q-10，混合均匀，得到含有氨基酸的混合液；
六、将柿子叶(Diospyros kaki)在无菌情况下，使用无菌剪机械剪成叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于55℃～65℃震荡水解处理，离心收集上清液，然后将上清液放入10KD超滤管中离心，收集的液相为柿叶活性小分子多肽，柿叶活性小分子多肽与含有氨基酸的混合液混合，得到含有柿叶活性小分子多肽的混合液；
七、向含有柿叶活性小分子多肽的混合液加入三乙醇胺调节体系的pH为5-7，搅拌混合均匀，得到精华液；
八、将精华液吸收于面膜布上，得到含有柿叶提取物的氨基酸面膜。
具体实施方式六：本实施方式与具体实施方式五不同的是步骤一中按照质量百分含量称取卡波姆B型2％、三乙醇胺0.1％、甘油10％、透明质酸钠1％、对羟基苯甲酸甲酯0.1％、维生素C 0.5％、维生素E 0.5％、EDTA-二钠0.1％、柿叶活性小分子多肽5％、芦荟提取物0.5％、赖氨酸0.5％、色氨酸0.5％、苯丙氨酸0.5％、甲硫氨酸0.5％、苏氨酸0.5％、异亮氨酸0.5％、亮氨酸0.5％、缬氨酸0.5％、辅羧酶0.5％、辅酶A0.5％、黄素腺嘌呤二核苷酸0.5％、烟酰胺腺嘌呤二核苷酸核酸0.5％、辅酶II 0.5％、尿苷三磷酸0.5％、辅酶Q-100.5％，余量为纯化水作为面膜精华液原料。
具体实施方式七：本实施方式与具体实施方式五或六不同的是步骤二加热到80℃，以60r/min搅拌1小时。
具体实施方式八：本实施方式与具体实施方式五至七之一不同的是步骤四中搅拌的速度为60r/min，搅拌时间为20分钟。
具体实施方式九：本实施方式与具体实施方式五至八之一不同的是步骤六中叶块的面积小于0.2mm3。
具体实施方式十：本实施方式与具体实施方式五至九之一不同的是步骤六中复合酶和叶块的质量比为1:4。
具体实施方式十一：本实施方式与具体实施方式五至十之一不同的是步骤六中在pH＝7.0条件下复合酶和叶块于55℃～65℃震荡水解处理5小时。
实施例：本实施例含有柿叶提取物的氨基酸面膜的制备方法按照以下步骤实施：
一、按照质量百分含量称取卡波姆B型2％、三乙醇胺0.1％、甘油10％、透明质酸钠1％、对羟基苯甲酸甲酯0.1％、维生素C 0.5％、维生素E 0.5％、EDTA-二钠0.1％、柿叶活性小分子多肽5％、芦荟提取物0.5％、赖氨酸0.5％、色氨酸0.5％、苯丙氨酸0.5％、甲硫氨酸0.5％、苏氨酸0.5％、异亮氨酸0.5％、亮氨酸0.5％、缬氨酸0.5％、辅羧酶0.5％、辅酶A0.5％、黄素腺嘌呤二核苷酸0.5％、烟酰胺腺嘌呤二核苷酸核酸0.5％、辅酶II 0.5％、尿苷三磷酸0.5％、辅酶Q-10 0.5％，余量为纯化水作为面膜精华液原料；
二、将步骤一原料中的纯化水、卡波姆、甘油、对羟基苯甲酸甲酯、EDTA-二钠、芦荟提取物加热到80℃，60r/min持续搅拌1小时，得到精华基液；
三、精华基液冷却至37℃后，以功率为200W,频率为25KHz的超声波进行均质混合，得到混合剂；
四、向混合剂中加入原料中的透明质酸钠、维生素C和维生素E，60r/min持续搅拌20分钟，得到含有维生素的混合剂；
五、向含有维生素的混合剂中加入原料中的赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸和辅酶Q-10，20rpm/min搅拌30分钟至混合均匀，得到含有氨基酸的混合液；
六、将柿子叶(Diospyros kaki)在无菌情况下，使用无菌剪机械剪成小于0.2mm3的叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于60℃震荡水解5小时(叶块放入复合酶中水解)，复合酶和与叶块质量比为1:4，3500rpm离心30min后取上清液，然后将上清液放入10KD超滤管中10000r/min离心20分钟，收集的液相为柿叶活性小分子多肽，柿叶活性小分子多肽与含有氨基酸的混合液混合，得到含有柿叶活性小分子多肽的混合液；
七、向含有柿叶活性小分子多肽的混合液加入三乙醇胺调节体系的pH为7，搅拌混合均匀，得到精华液；
八、将精华液吸收于面膜布上，热缩包装得到含有柿叶提取物的氨基酸面膜。
随机选取市场上其他三种面膜分别编号为对照1-3，将本实施例配方中的柿叶活性小分子多肽改为商购的柿叶提取物，其他不变，编号为对照4和本实施例分别对比补水、美白、抗衰、过敏程度。
分别对各种面膜使用1个月、三个月、六个月和停用后三个月的效果进行评价。评价方法：选取100位志愿者进行面膜使用，其中，50名志愿者面部暗黄并皮肤干燥、50志愿者面部具有皮肤松弛衰老，易过敏特征。针对面部干燥、暗黄、衰老问题，首先各志愿者对面膜进行使用并确定使用效果，根据自我感觉按照标准进行打分，其后由工作人员使用比色卡记录肤色等级，使用武汉长荣电子科技有限公司Skin moisture and oil contentanalyzer检测面部皮肤含水量，使用美国Canfield公司面部图像分析系统VISIA检测面部表皮皱纹分析。
评价标准为：
针对补水、美白、抗衰、过敏程度志愿者自我评价结果：
针对补水、美白、抗衰程度仪器检测结果：
从上表中可以看出，使用本发明上述面膜不仅不易导致皮肤过敏，并能够显著改善或避免面部干燥、暗黄、衰老问题。
柿叶活性小分子肽相较于单纯柿叶提取物作用于面部后美白、保湿、抗衰的有益效果产生的更快，并且在停用后能够更长时间的保持美容效果。
Claims (10)
1.含有柿叶提取物的氨基酸面膜，其特征在于该含有柿叶提取物的氨基酸面膜包括面膜精华液和面膜布，其中面膜精华液包括卡波姆B型、三乙醇胺、甘油、透明质酸钠、对羟基苯甲酸甲酯、维生素C、维生素E、EDTA-二钠、柿叶活性小分子多肽、芦荟提取物、赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸、辅酶Q-10和余量的水。
2.根据权利要求1所述的含有柿叶提取物的氨基酸面膜，其特征在于面膜精华液包括卡波姆B型1％～3％、三乙醇胺0.08％～0.2％、甘油8％～14％、透明质酸钠0.8％～1.4％、对羟基苯甲酸甲酯0.08％～0.12％、维生素C 0.3％～0.6％、维生素E 0.3％～0.6％、EDTA-二钠0.08％～0.12％、柿叶活性小分子多肽3％～6％、芦荟提取物0.3％～0.6％、赖氨酸0.3％～0.6％、色氨酸0.3％～0.6％、苯丙氨酸0.3％～0.6％、甲硫氨酸0.3％～0.6％、苏氨酸0.3％～0.6％、异亮氨酸0.3％～0.6％、亮氨酸0.3％～0.6％、缬氨酸0.3％～0.6％、辅羧酶0.3％～0.6％、辅酶A0.3％～0.6％、黄素腺嘌呤二核苷酸0.3％～0.6％、烟酰胺腺嘌呤二核苷酸核酸0.3％～0.6％、辅酶II 0.3％～0.6％、尿苷三磷酸0.3％～0.6％、辅酶Q-10 0.3％～0.6％和余量的水。
3.根据权利要求1所述的含有柿叶提取物的氨基酸面膜，其特征在于所述的柿叶活性小分子多肽的制备方法如下：
将柿子叶在无菌情况下，使用无菌剪机械剪成叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于55℃～65℃温度下震荡水解处理，离心收集上清液，然后将上清液放入10KD超滤管中离心，收集的液相即为柿叶活性小分子多肽。
4.根据权利要求1所述的含有柿叶提取物的氨基酸面膜，其特征在于该含有柿叶提取物的氨基酸面膜在面膜布上还贴附有珠光膜。
5.含有柿叶提取物的氨基酸面膜的制备方法，其特征在于该制备方法按下列步骤实现：
一、按照质量百分含量称取卡波姆B型1％～3％、三乙醇胺0.08％～0.2％、甘油8％～14％、透明质酸钠0.8％～1.4％、对羟基苯甲酸甲酯0.08％～0.12％、维生素C 0.3％～0.6％、维生素E 0.3％～0.6％、EDTA-二钠0.08％～0.12％、柿叶活性小分子多肽3％～6％、芦荟提取物0.3％～0.6％、赖氨酸0.3％～0.6％、色氨酸0.3％～0.6％、苯丙氨酸0.3％～0.6％、甲硫氨酸0.3％～0.6％、苏氨酸0.3％～0.6％、异亮氨酸0.3％～0.6％、亮氨酸0.3％～0.6％、缬氨酸0.3％～0.6％、辅羧酶0.3％～0.6％、辅酶A 0.3％～0.6％、黄素腺嘌呤二核苷酸0.3％～0.6％、烟酰胺腺嘌呤二核苷酸核酸0.3％～0.6％、辅酶II0.3％～0.6％、尿苷三磷酸0.3％～0.6％、辅酶0.3％～0.6％，余量为纯化水作为面膜精华液原料；
二、将步骤一原料中的纯化水、卡波姆、甘油、对羟基苯甲酸甲酯、EDTA-二钠、芦荟提取物加热到75℃～85℃，搅拌均匀，得到精华基液；
三、精华基液冷却至35℃～39℃后，采用超声波进行均质混合，得到混合剂；
四、向混合剂中加入原料中的透明质酸钠、维生素C和维生素E，搅拌均匀，得到含有维生素的混合剂；
五、向含有维生素的混合剂中加入原料中的赖氨酸、色氨酸、苯丙氨酸、甲硫氨酸、苏氨酸、异亮氨酸、亮氨酸、缬氨酸、辅羧酶、辅酶A、黄素腺嘌呤二核苷酸、烟酰胺腺嘌呤二核苷酸核酸、辅酶II、尿苷三磷酸和辅酶Q-10，混合均匀，得到含有氨基酸的混合液；
六、将柿子叶在无菌情况下，使用无菌剪机械剪成叶块，由质量比为1：1的中性蛋白酶与碱性蛋白酶组成复合酶，在pH＝7.0条件下复合酶和叶块于55℃～65℃震荡水解处理，离心收集上清液，然后将上清液放入10KD超滤管中离心，收集的液相为柿叶活性小分子多肽，柿叶活性小分子多肽与含有氨基酸的混合液混合，得到含有柿叶活性小分子多肽的混合液；
七、向含有柿叶活性小分子多肽的混合液加入三乙醇胺调节体系的pH为5-7，搅拌混合均匀，得到精华液；
八、将精华液吸收于面膜布上，得到含有柿叶提取物的氨基酸面膜。
6.根据权利要求5所述的含有柿叶提取物的氨基酸面膜的制备方法，其特征在于步骤一中按照质量百分含量称取卡波姆B型2％、三乙醇胺0.1％、甘油10％、透明质酸钠1％、对羟基苯甲酸甲酯0.1％、维生素C 0.5％、维生素E 0.5％、EDTA-二钠0.1％、柿叶活性小分子多肽5％、芦荟提取物0.5％、赖氨酸0.5％、色氨酸0.5％、苯丙氨酸0.5％、甲硫氨酸0.5％、苏氨酸0.5％、异亮氨酸0.5％、亮氨酸0.5％、缬氨酸0.5％、辅羧酶0.5％、辅酶A0.5％、黄素腺嘌呤二核苷酸0.5％、烟酰胺腺嘌呤二核苷酸核酸0.5％、辅酶II 0.5％、尿苷三磷酸0.5％、辅酶Q-10 0.5％，余量为纯化水作为面膜精华液原料。
7.根据权利要求5所述的含有柿叶提取物的氨基酸面膜的制备方法，其特征在于步骤二加热到80℃，以60r/min搅拌1小时。
8.根据权利要求5所述的含有柿叶提取物的氨基酸面膜的制备方法，其特征在于步骤四中搅拌的速度为60r/min，搅拌时间为20分钟。
9.根据权利要求5所述的含有柿叶提取物的氨基酸面膜的制备方法，其特征在于步骤六中复合酶和叶块的质量比为1:4。
10.根据权利要求5所述的含有柿叶提取物的氨基酸面膜的制备方法，其特征在于步骤六中在pH＝7.0条件下复合酶和叶块于55℃～65℃震荡水解处理5小时。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010589805.XA CN111686024B (zh) | 2020-06-24 | 2020-06-24 | 含有柿叶提取物的氨基酸面膜及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010589805.XA CN111686024B (zh) | 2020-06-24 | 2020-06-24 | 含有柿叶提取物的氨基酸面膜及其制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN111686024A true CN111686024A (zh) | 2020-09-22 |
| CN111686024B CN111686024B (zh) | 2022-12-16 |
Family
ID=72483772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010589805.XA Active CN111686024B (zh) | 2020-06-24 | 2020-06-24 | 含有柿叶提取物的氨基酸面膜及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111686024B (zh) |
Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002003353A (ja) * | 2000-06-19 | 2002-01-09 | Kansai Koso Kk | メチオナーゼ及び／又はプロテアーゼ阻害剤及び口腔用組成物 |
| KR20040081248A (ko) * | 2003-03-14 | 2004-09-21 | (주)에코텍 | 울금추출물이 함유된 기능성 한방입욕제의 제조방법 |
| EP1872658A1 (en) * | 2005-03-31 | 2008-01-02 | Mitsui Chemicals, Inc. | Pesticidal composition |
| CN102846518A (zh) * | 2012-10-08 | 2013-01-02 | 南宁骄阳医药科技有限公司 | 一种微波萃取与膜分离联用提取柿叶果酸的方法 |
| CN103040692A (zh) * | 2012-11-15 | 2013-04-17 | 北京一轻研究院 | 一种用于皮肤美白的组合物 |
| CN104173256A (zh) * | 2014-08-11 | 2014-12-03 | 杨磊 | 赋养补水保湿乳液 |
| CN104490662A (zh) * | 2014-12-04 | 2015-04-08 | 云南人羞花化妆品有限公司 | 一种三七养肤护颈露及其制备方法 |
| CN107440963A (zh) * | 2017-08-23 | 2017-12-08 | 佛山市三水区嘉华化学研究院（普通合伙） | 一种具有美白抗衰老活性的柿叶黄酮及其制备方法和应用 |
| CN107468568A (zh) * | 2017-08-23 | 2017-12-15 | 佛山市三水区嘉华化学研究院（普通合伙） | 一种具有美白防晒活性的柿叶多酚及其制备方法和应用 |
| CN108113927A (zh) * | 2018-02-28 | 2018-06-05 | 周海英 | 一种用于化妆品中的具有美白功效的组合物及其制备方法 |
-
2020
- 2020-06-24 CN CN202010589805.XA patent/CN111686024B/zh active Active
Patent Citations (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002003353A (ja) * | 2000-06-19 | 2002-01-09 | Kansai Koso Kk | メチオナーゼ及び／又はプロテアーゼ阻害剤及び口腔用組成物 |
| KR20040081248A (ko) * | 2003-03-14 | 2004-09-21 | (주)에코텍 | 울금추출물이 함유된 기능성 한방입욕제의 제조방법 |
| EP1872658A1 (en) * | 2005-03-31 | 2008-01-02 | Mitsui Chemicals, Inc. | Pesticidal composition |
| CN102846518A (zh) * | 2012-10-08 | 2013-01-02 | 南宁骄阳医药科技有限公司 | 一种微波萃取与膜分离联用提取柿叶果酸的方法 |
| CN103040692A (zh) * | 2012-11-15 | 2013-04-17 | 北京一轻研究院 | 一种用于皮肤美白的组合物 |
| CN104173256A (zh) * | 2014-08-11 | 2014-12-03 | 杨磊 | 赋养补水保湿乳液 |
| CN104490662A (zh) * | 2014-12-04 | 2015-04-08 | 云南人羞花化妆品有限公司 | 一种三七养肤护颈露及其制备方法 |
| CN107440963A (zh) * | 2017-08-23 | 2017-12-08 | 佛山市三水区嘉华化学研究院（普通合伙） | 一种具有美白抗衰老活性的柿叶黄酮及其制备方法和应用 |
| CN107468568A (zh) * | 2017-08-23 | 2017-12-15 | 佛山市三水区嘉华化学研究院（普通合伙） | 一种具有美白防晒活性的柿叶多酚及其制备方法和应用 |
| CN108113927A (zh) * | 2018-02-28 | 2018-06-05 | 周海英 | 一种用于化妆品中的具有美白功效的组合物及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| YANG SJ, ETAL: "Diospyros kaki Extract Inhibits Alkali Burn-Induced Corneal Neovascularization", 《MED FOOD》 * |
| 鲁军，等: "柿叶多酚的提取及体外生物活性的研究", 《食品工业科技》 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN111686024B (zh) | 2022-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN111658818B (zh) | 一种医用修复敷料及其应用 | |
| CN101787078B (zh) | 一种胶原蛋白多肽及其制备方法和用途 | |
| CN110037952A (zh) | 一种抗皱及淡化黑眼圈眼膜贴 | |
| CN113786362B (zh) | 一种具有舒缓平衡护肤功效的化妆水组合物及其制备方法 | |
| CN105168054A (zh) | 一种补水增白祛皱面膜及其制备方法 | |
| CN111228130B (zh) | 一种具有激发皮肤细胞能量、修复皮肤屏障功效的组合物及其制备方法与应用 | |
| CN106619177A (zh) | 一种白牦牛骨胶原蛋白肽美白保湿化妆品及其制备方法 | |
| CN109260116A (zh) | 一种含有植物提取物的至肽肌底液及其生产工艺 | |
| CN111481475A (zh) | 一种改善女性荷尔蒙的可食性唇膏及其制备方法 | |
| CN109528536A (zh) | 一种含有胆碱鞣花酸盐的护肤品及其制备方法 | |
| CN113384482A (zh) | 一种保湿嫩肤精华露及其制备方法 | |
| CN105310972A (zh) | 一种抗皱护肤品 | |
| CN111686024B (zh) | 含有柿叶提取物的氨基酸面膜及其制备方法 | |
| CN111358710A (zh) | 一种保湿舒缓阿胶面霜及其制备方法 | |
| CN103599054B (zh) | 含花生蛋白多肽的面膜及其制备方法 | |
| CN115844804A (zh) | 一种改善外源性衰老的组合物及其制备方法与应用 | |
| CN112972314B (zh) | 一种眼部修护组合物及其制备方法和应用 | |
| KR101806007B1 (ko) | 나노화된 천연 성분이 함유된 화장료 조성물의 제조방법 및 그 제조방법을 통해 제조되는 화장료 조성물 | |
| CN108542829A (zh) | 一种植物保湿防晒霜及其制备方法 | |
| CN111939096B (zh) | 一种含四氢嘧啶的保湿护肤乳及其制备方法 | |
| CN105168067B (zh) | 一种活力祛斑精华液及其制备方法 | |
| CN109646359B (zh) | 一种具有清洁净化和美容养颜功效的玫瑰木耳泥膜膏及其制备方法 | |
| CN107308071A (zh) | 一种加入了聚谷氨酸的枸杞面膜及其制备方法 | |
| CN105193703A (zh) | 皮肤外用抗皱组合物 | |
| CN109288721A (zh) | 一种含苹果干细胞生长因子的面膜液及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20240313 Address after: Building A, 2nd Floor, Incubator Building, Huangjinkou Technology Enterprise Incubation Industry Base, No. 270, Huangjinkou San Village, Hanyang District, Wuhan City, Hubei Province, 430000 Patentee after: Wuhan Tianqing stem cell Co.,Ltd. Country or region after: China Address before: 150028 Heilongjiang Harbin Harbin hi tech Industrial Development Zone, science and technology innovation city 199 treasure road two Patentee before: TIANQING STEM CELL CO.,LTD. Country or region before: China |
|
| TR01 | Transfer of patent right |